# Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain

> **NCT04593329** · PHASE2 · WITHDRAWN · sponsor: **EMS**

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** TIRADENTES ASSOCIATION
- **DRUG:** DIPYRONE
- **DRUG:** TRAMADOL
- **OTHER:** TIRADENTES ASSOCIATION PLACEBO
- **OTHER:** DIPYRONE PLACEBO
- **OTHER:** TRAMADOL PLACEBO

## Key facts

- **NCT ID:** NCT04593329
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03
- **Primary completion:** 2023-08
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategy review
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04593329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04593329, "Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04593329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*